Gateway Investment Advisers’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $437K | Sell |
2,241
-884
| -28% | -$183K | ﹤0.01% | 621 |
|
|
2026
Q1 | $702K | Buy |
3,125
+673
| +27% | +$168K | 0.01% | 405 |
|
|
2025
Q4 | $591K | Buy |
2,452
+1,177
| +92% | +$301K | 0.01% | 431 |
|
|
2025
Q3 | $349K | Buy |
+1,275
| New | +$348K | ﹤0.01% | 452 |
|
|
2025
Q2 | – | Sell |
-3,486
| Closed | -$780K | – | 507 |
|
|
2025
Q1 | $780K | Sell |
3,486
-1,154
| -25% | -$269K | 0.01% | 355 |
|
|
2024
Q4 | $1.06M | Sell |
4,640
-782
| -14% | -$188K | 0.01% | 320 |
|
|
2024
Q3 | $1.32M | Buy |
5,422
+2,034
| +60% | +$455K | 0.01% | 292 |
|
|
2024
Q2 | $649K | Sell |
3,388
-792
| -19% | -$161K | 0.01% | 365 |
|
|
2024
Q1 | $828K | Sell |
4,180
-34
| -0.8% | -$6.23K | 0.01% | 346 |
|
|
2023
Q4 | $725K | Buy |
4,214
+11
| +0.3% | +$1.69K | 0.01% | 358 |
|
|
2023
Q3 | $621K | Buy |
4,203
+940
| +29% | +$170K | 0.01% | 365 |
|
|
2023
Q2 | $713K | Sell |
3,263
-7
| -0.2% | -$1.56K | 0.01% | 349 |
|
|
2023
Q1 | $716K | Buy |
3,270
+639
| +24% | +$139K | 0.01% | 356 |
|
|
2022
Q4 | $548K | Buy |
2,631
+240
| +10% | +$52.7K | 0.01% | 401 |
|
|
2022
Q3 | $522K | Buy |
2,391
+214
| +10% | +$48.7K | 0.01% | 403 |
|
|
2022
Q2 | $456K | Buy |
2,177
+19
| +0.9% | +$4.04K | 0.01% | 431 |
|
|
2022
Q1 | $523K | Buy |
2,158
+143
| +7% | +$34.6K | 0.01% | 427 |
|
|
2021
Q4 | $525K | Sell |
2,015
-75
| -4% | -$19.5K | 0.01% | 417 |
|
|
2021
Q3 | $551K | Sell |
2,090
-28
| -1% | -$7.66K | 0.01% | 406 |
|
|
2021
Q2 | $522K | Sell |
2,118
-32
| -1% | -$6.73K | 0.01% | 423 |
|
|
2021
Q1 | $417K | Sell |
2,150
-60
| -3% | -$12K | ﹤0.01% | 440 |
|
|
2020
Q4 | $470K | Sell |
2,210
-132
| -6% | -$26.3K | 0.01% | 418 |
|
|
2020
Q3 | $401K | Sell |
2,342
-97,353
| -98% | -$18M | ﹤0.01% | 423 |
|
|
2020
Q2 | $19.1M | Sell |
99,695
-304
| -0.3% | -$49.7K | 0.23% | 100 |
|
|
2020
Q1 | $14.7M | Sell |
99,999
-8,801
| -8% | -$1.4M | 0.18% | 115 |
|
|
2019
Q4 | $16.9M | Sell |
108,800
-2,649
| -2% | -$382K | 0.17% | 132 |
|
|
2019
Q3 | $15.1M | Sell |
111,449
-3,987
| -3% | -$522K | 0.15% | 147 |
|
|
2019
Q2 | $14.1M | Sell |
115,436
-264
| -0.2% | -$29.2K | 0.13% | 161 |
|
|
2019
Q1 | $12M | Sell |
115,700
-7,426
| -6% | -$766K | 0.11% | 177 |
|
|
2018
Q4 | $14M | Sell |
123,126
-190
| -0.2% | -$20.4K | 0.13% | 158 |
|
|
2018
Q3 | $14.2M | Buy |
123,316
+6,739
| +6% | +$738K | 0.12% | 171 |
|
|
2018
Q2 | $12.1M | Sell |
116,577
-635
| -0.5% | -$64.3K | 0.11% | 181 |
|
|
2018
Q1 | $11.5M | Sell |
117,212
-1,462
| -1% | -$138K | 0.1% | 186 |
|
|
2017
Q4 | $10.1M | Sell |
118,674
-37,330
| -24% | -$3.08M | 0.09% | 195 |
|
|
2017
Q3 | $12M | Buy |
156,004
+54,058
| +53% | +$4.14M | 0.1% | 182 |
|
|
2017
Q2 | $7.94M | Buy |
101,946
+16,565
| +19% | +$1.19M | 0.07% | 215 |
|
|
2017
Q1 | $6.14M | Buy |
85,381
+26,015
| +44% | +$1.8M | 0.06% | 242 |
|
|
2016
Q4 | $3.68M | Sell |
59,366
-18,492
| -24% | -$1.13M | 0.03% | 299 |
|
|
2016
Q3 | $5.04M | Buy |
77,858
+2,000
| +3% | +$133K | 0.04% | 263 |
|
|
2016
Q2 | $4.8M | Buy |
75,858
+122
| +0.2% | +$7.19K | 0.04% | 273 |
|
|
2016
Q1 | $4.38M | Sell |
75,736
-27,708
| -27% | -$1.57M | 0.04% | 270 |
|
|
2015
Q4 | $5.55M | Buy |
103,444
+14,661
| +17% | +$826K | 0.05% | 260 |
|
|
2015
Q3 | $4.52M | Buy |
88,783
+572
| +0.6% | +$30.8K | 0.04% | 284 |
|
|
2015
Q2 | $4.97M | Buy |
+88,211
| New | +$5.57M | 0.04% | 278 |
|
Other funds holding RMD
AT
CISOA
DJSG
MIF
CIM
AC
Gateway Investment Advisers's RMD Position: Q2 2026 in Review
Gateway Investment Advisers reduced its ResMed (RMD) stake by 28% in Q2 2026, selling an estimated $183K and leaving 2,241 shares worth $437K. The position accounts for ﹤0.01% of the portfolio, ranked #621.
Gateway Investment Advisers first reported a position in RMD in Q2 2015 and has held it in 44 quarters since. The position peaked at $19.1M in Q2 2020. 179 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Gateway Investment Advisers held 2,241 shares of ResMed worth $437K as of Q2 2026.
- Gateway Investment Advisers sold 884 ResMed shares in Q2 2026, an estimated $183K.
- ResMed made up ﹤0.01% of Gateway Investment Advisers's portfolio in Q2 2026, its #621 holding.
- Gateway Investment Advisers first reported a position in ResMed in Q2 2015 and has held it in 44 quarters since.
- Gateway Investment Advisers's ResMed position peaked at $19.1M in Q2 2020.
- 179 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.